Accel Wealth Management Abbott Laboratories Transaction History
Accel Wealth Management
- $328 Million
- Q3 2025
A detailed history of Accel Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Accel Wealth Management holds 2,468 shares of ABT stock, worth $305,637. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,468
Previous 2,566
3.82%
Holding current value
$305,637
Previous $349,000
5.44%
% of portfolio
0.1%
Previous 0.12%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,611Shares Held
1.39BCall Options Held
9.22MPut Options Held
8.09M-
Vanguard Group Inc Valley Forge, PA173MShares$21.4 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.7 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.45 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.17 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $217B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...